Medtronic has announced a limited rollout of its intelligent Signia Circular Stapler, which incorporates Tri-Staple technology, for surgical procedures involving the alimentary tract.
This device is designed to construct end-to-side, end-to-end and side-to-side anastomoses in both open and laparoscopic surgeries.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The stapler offers powered clamping, enhanced perfusion at the staple site and limited tissue stress during the process.
Regulatory approval has been secured for this technology in several markets including Western Europe, Japan and the US.
According to the company, circular staplers are usually employed in colorectal resection surgeries, a standard approach for treating colon cancer and the main method for addressing rectal cancer.
One of the main risks associated with these surgeries is anastomotic leakage, which can occur if the colon ends are not properly joined.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSuch leaks may lead to exposure of gut contents and a higher risk of infection, with the incidence reaching up to 19% in some cases, the company noted.
Medtronic Core Surgical Innovations chief medical officer Dr Matthew Kroh said: “We are excited to bring the Tri-Staple technology that many surgeons have come to rely on in our Signia linear staplers to procedures that require circular staplers, such as colorectal resection.
“With superior performance, intelligent feedback, and a unique set of features that enable greater perfusion and more protection against leaks, surgeons can now rely on the Signia circular stapler to deliver a confident staple line.”
Among its other attributes, the stapler is said to reduce distal tip movement during use by up to 53% and cut procedural waste by 88% due to its reusable handle.
The stapler integrates Tri-Staple and Adaptive Compression technologies for monitoring and adjusting the compression applied, which may help avoid excessive compression and potential tissue damage.
This approach is expected to decrease the likelihood of haematoma by as much as 80% and offers enhanced perfusion at the staple line by up to 164%.
